Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DCX | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
mRNA | FAM221A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
mRNA | IPO4 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | ZNF501 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | CHST1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | GRB10 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | INPPL1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | VPREB1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | FAM64A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | GOT1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |